Does LORAZEPAM Cause Product dose omission issue? 115 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Product dose omission issue have been filed in association with LORAZEPAM (Lorazepam). This represents 0.3% of all adverse event reports for LORAZEPAM.
115
Reports of Product dose omission issue with LORAZEPAM
0.3%
of all LORAZEPAM reports
0
Deaths
81
Hospitalizations
How Dangerous Is Product dose omission issue From LORAZEPAM?
Of the 115 reports, 81 (70.4%) required hospitalization, and 2 (1.7%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LORAZEPAM Alternatives Have Lower Product dose omission issue Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN